Please login to the form below

Not currently logged in

ASH 2018

This page shows the latest ASH 2018 news and features for those working in and with pharma, biotech and healthcare.

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

new data at the ASH 2018 congress in multiple myeloma. ... Amgen also reported data at ASH on another BiTE candidate called AMG 330 which targets CD33, the same target as Regeneron’s REGN1979 which posted results in lymphoma earlier during the

Latest news

  • Regeneron’s early stage bispecific shows promise Regeneron’s early stage bispecific shows promise

    Regeneron is one many companies developing bispecifics, and on Saturday at the ASH 2018 congress in San Diego, unveiled phase 1 proof of concept data for its REGN1979 in relapsed or ... Also presenting bispecific antibodies at ASH are Amgen (AMG 420) and

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Highlights in haematologic malignancy from ASH 2018

    The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. ... If you would like to discuss insights from ASH 2018 or have any

  • Porterhouse Medical Group Porterhouse Medical Group

    Highlights in haematologic malignancy from ASH 2018. ... 2018. Communique Awards Finalist 'Healthcare Communications Leader'. 2017. Communique Awards Finalist 'Medical Education Consultancy of the Year'.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...